Skip to main content

Advertisement

Table 1 Demographic characteristics

From: Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome

  Valvar (n = 20) P* value CAD/MS group
Control (n = 17) Simvastatin (n = 20) Pioglitazone (n = 18) Pioglitazone + Simvastatin (n = 18) P** value
Age (yrs) 52.3 ± 8.0 <0.001 64.3 ± 6.06 60.1 ± 6.38 57.6 ± 5.89 60.1 ± 7.08 0.024
Male (%) 6(30) 0.005 12(70.6) 16(80) 10 (55.6) 10 (55.6) 0.314
Waist circumference (cm) 78.4 ± 11.9 <0.001 103.6 ± 6.43 103.2 ± 8.62 103.7 ± 8.09 105.2 ± 9.06 0.883
Systolic BP (mmHg) 113 ± 10.3 <0.001 145 ± 17.1 134 ± 15.1 162 ± 20.3 145 ± 13.8 <0.001
Diastolic BP (mmHg) 72 ± 11.5 0.006 87 ± 11.8 78 ± 10.3 85 ± 12 73 ± 11.2 0.001
Baseline Weight (Kg) 58.9 ± 12.4 <0.001 85.8 ± 13.7 76.7 ± 10.8 80.6 ± 13.7 83.9 ± 10.2 0.122
Final Weight (Kg) 57.2 ± 11.9 <0.001 82.5 ± 12.9 74.6 ± 10.5 81.4 ± 14.6 83.3 ± 9.3 0.102
  1. Values are means ± SD or n(%). CAD = coronary artery disease; BP = blood pressure. P* value = Comparison between non-CAD group and CAD/MS group. P** value = Comparison between CAD/MS groups.